Research Article
Modelling the Drugs Therapy for HIV Infection with Discrete-Time Delay
Table 1
Variables and parameters for viral spread.
| Variables and meaning parameters | Values |
| | Uninfected CD4+ T-cell population size | 1000 mm−3 | | Pre-RT | 0 mm−3 | | Post-RT | 0 mm−3 | | Infectious virus | 10−3 mm−3 |
| | Source term for uninfected CD4+ T-cell | 5 day −1 mm−3 | | Rate at which CD4+ T-cell becomes infected with virus | 0.00005 mm3 day−1 | | Death rate of healthy CD4+ T-cell | 0.01 day−1 | | Efficacy of RTIs | 0.15 | | Transition rate from pre-RT infected CD4+ T cells to productively post-RT | 0.4 day−1 | | Reverting rate of infected cells to uninfected class | 0.05 day−1 | | Death rate of infected T-cells | 0.015 day−1 | | Death rate of actively infected T-cells | 0.6 day−1 | | Number of virions produced by infected CD4+ T-cells | 1000 virions cell−1 | | Clearance rate of virus | 2.4 day−1 | | Growth rate of T-cells | 0.8 day−1 | | Carrying capacity of T-cells | 1300 mm3 | | Protease inhibitor efficacy | 0.1 |
|
|